Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

25 Apr, 2019, 13:30 BST Roche Presented Caprion Biosciences' Data on Targeted Mass Spectrometry for Clinical Proteomics

Caprion Biosciences is pleased to announce the completion of a collaborative study using mass spectrometry to quantify biomarkers in clinical samples....


25 Apr, 2019, 12:30 BST GT Biopharma (GTBP) to Broadcast Update on TriKE Initiatives for HIV and Oncology at University of Minnesota On May 7th; Dr. Jeff Miller And Dr. Timothy Schacker to Host Event

GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA), an immuno-oncology biotechnology company focused on innovative treatments based on the Company's...


25 Apr, 2019, 07:00 BST Less Than a Quarter of UK Adults Surveyed Are Aware of or Up-to-Date With Vaccinations[i]

Misinformation on social media, a growing complacency of vaccinations and gaps in vaccination coverage, are cited as main reasons for the return of...


24 Apr, 2019, 12:30 BST GT Biopharma (GTBP) Announces the Elimination of HIV Infected Cells Using its Tri-Specific Killer Engagers (TriKEs) in Preclinical Testing at the University of Minnesota

GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology biotechnology company focused on innovative treatments based on the Company's...


24 Apr, 2019, 10:00 BST Alchem International Solves Stability Dilemma for Micronized Digoxin and Files Patent for Novel Production Process

Alchem International Private Limited ("Alchem"), a privately held pharmaceutical company focusing on the production of plant-derived active...


24 Apr, 2019, 06:48 BST Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the company will provide an update on patient recruitment in the ongoing phase 3 study...


23 Apr, 2019, 14:00 BST PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection

The results of a pilot study using Longhorn Vaccines and Diagnostics's patented sample collection technology, PrimeStore® MTM, were presented at the...


23 Apr, 2019, 06:54 BST BerGenBio to Present NSCLC and AML Clinical Data From Phase II Development Programme With Selective AXL Inhibitor Bemcentinib at ASCO 2019

BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer...


18 Apr, 2019, 14:30 BST TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy

TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a monoclonal antibody...


18 Apr, 2019, 08:35 BST Cantargia Phase I Clinical Results on the Antibody CAN04 Selected for Oral Presentation at ASCO

Cantargia AB today announce that the phase I clinical data generated by the antibody CAN04 will be presented orally at the 2019 Annual ASCO meeting...


17 Apr, 2019, 14:00 BST Widespread Clinical Studies Can Reinvigorate the Legalization Movement for Cannabis

Researchers and scientists are constantly developing new, innovative medicines to effectively treat patients. However, the cost to conduct clinical...


17 Apr, 2019, 07:29 BST Alligator Bioscience AB (publ) Interim Report January-March 2019

Significant events January-March First patient dosed in Phase I clinical study of ATOR-1015. New preclinical data presented demonstrating strong...


16 Apr, 2019, 15:22 BST New Publication Validates Clinical Performance of Signatera for Recurrence Monitoring and MRD Assessment in Breast Cancer

Natera, Inc. (NASDAQ: NTRA), Cancer Research UK, Imperial College London and the University of Leicester, today announced the publication of results...


16 Apr, 2019, 08:30 BST AMO Pharma Announces Launch of First Clinician-Completed Rating Scale for Congenital Myotonic Dystrophy Type 1

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited...


15 Apr, 2019, 09:00 BST Norgine: New Real World Study Shows Rifaximin-a Significantly Reduced Hospitalisation in Patients With Overt Hepatic Encephalopathy (HE) When Added to Lactulose

Norgine B.V. today highlighted results of a real world study showing significant reductions in the number and length of hospitalisations when...


11 Apr, 2019, 19:12 BST InDex Pharmaceuticals Provides Status Update on the Patient Recruitment in the CONDUCT Study

InDex Pharmaceuticals Holding AB (publ) today announced that 197 patients, of the total 215 planned, have been enrolled to date in the CONDUCT study...


11 Apr, 2019, 13:30 BST Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market

Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the...


11 Apr, 2019, 12:49 BST LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today...


11 Apr, 2019, 12:00 BST Completion of the First Interventional Phase-II Trial in the Innovative Medicines Initiative's New Drugs 4 Bad Bugs Programme

The Innovative Medicines Initiative (IMI)-funded COMBACTE-NET (Combatting Bacterial Resistance in Europe) consortium has completed the SAATELLITE...


11 Apr, 2019, 08:00 BST GenePOC Obtains CE Marked for Its GenePOC™ Carba Test

GenePOC Inc., member of the Debiopharm Group, announces its third test to be CE marked, the GenePOC Carba assay, to be used with the revogene™ device....


10 Apr, 2019, 09:53 BST Alligator Bioscience to Present New Preclinical Data on ATOR-1015 at PEGS Boston

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Chief Medical Officer Charlotte Russell, MD, PhD, will give an oral presentation ...


10 Apr, 2019, 08:50 BST New study exposes need for better management of anaemia

A large study just published in the journal Anaesthesia raises important questions about the way anaemia is currently managed in surgical patients...


10 Apr, 2019, 06:24 BST Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL

Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of...


09 Apr, 2019, 16:35 BST Through Pioneering Clinical Research, Institute of Life IVF Center in Greece and Embryotools in Spain Achieve Global Innovation in Assisted Reproduction

The birth of the first healthy baby through the pioneering Maternal Spindle Transfer method – implemented for the first time by the Institute of Life ...


09 Apr, 2019, 13:30 BST Biotech Brief: Growing Number of Ongoing Clinical Trials for Leukemia (AML) Brings New Hope

In the last few years the number of clinical trials looking for new treatments for Leukemia (AML) has continued to grow. In 2017, a report from...